Gilead Sciences Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2016 | $30.39B | $17.63B | $13.50B |
| FY2017 | $26.11B | $14.12B | $4.63B |
| FY2018 | $22.13B | $8.20B | $5.46B |
| FY2019 | $22.45B | $4.29B | $5.39B |
| FY2020 | $24.69B | $4.07B | $123.0M |
| FY2021 | $27.31B | $9.92B | $6.23B |
| FY2022 | $27.28B | $7.33B | $4.59B |
| FY2023 | $27.12B | $7.61B | $5.67B |
| FY2024 | $28.75B | $1.66B | $480.0M |
| FY2025 | $29.44B | $10.02B | $8.51B |